Scn5a mutations in brugada syndrome are associated with increased cardiac dimensions and reduced contractility

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  van Hoorn, Frans ^a   Campian, Maria E ^a   Spijkerboer, Anje ^a   Blom, Marieke T ^a   Planken, R Nils ^a   van Rossum, Albert C ^b   de Bakker, Jacques M T ^a   Wilde, Arthur A M ^a   Groenink, Maarten ^a   Tan, Hanno L ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHANNEL NAV1.5;

ADULT; ARTICLE; BRUGADA SYNDROME; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART RIGHT VENTRICLE ENDDIASTOLIC PRESSURE; HEART RIGHT VENTRICLE VOLUME; HEART SIZE; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PATHOGENESIS; PREVALENCE; QRS PROLONGATION; QT PROLONGATION; SCN5A GENE;

ADULT; BRUGADA SYNDROME; ELECTROCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; MYOCARDIAL CONTRACTION; NAV1.5 VOLTAGE-GATED SODIUM CHANNEL;

EID: 84864493050     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042037     Document Type: Article

References (39)

1. Amin AS, Asghari-Roodsari A, Tan HL, ((2010)) Cardiac sodium channelopathies. Pflugers Arch 460:: 223-237.
2. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, et al. ((2005)) Brugada syndrome: report of the second consensus conference. Heart Rhythm 2:: 429-440.
3. Tan HL, Bink-Boelkens MT, Bezzina CR, Viswanathan PC, Beaufort-Krol GC, et al. ((2001)) A sodium-channel mutation causes isolated cardiac conduction disease. Nature 409:: 1043-1047.
4. Groenewegen AW, Firouzi M, Bezzina CR, Vliex S, van Langen IM, et al. ((2003)) A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ Res 92:: 14-22.
5. Wang DW, Viswanathan PC, Balser JR, George AL, Benson DW, ((2002)) Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation 105:: 341-346.
6. Benson DW, Wang DW, Dyment M, Knilans TK, Fish FA, et al. ((2003)) Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest 112:: 1019-1028.
7. Abriel H, ((2010)) Cardiac sodium channel Nav1.5 and interacting proteins: physiology and pathophysiology. J Mol Cell Cardiol 48:: 2-11.
8. Olson TM, Michels VV, Ballew JD, Reyna SP, Karst ML, et al. ((2005)) Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 293:: 447-454.
9. Coronel R, Casini S, Koopmann TT, Wilms-Schopman FJG, Verkerk AO, et al. ((2005)) Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation 112:: 2769-2777.
10. Hoogendijk MG, Potse M, Linnenbank AC, Verkerk AO, den Ruijter HM, et al. ((2010)) Mechanism of right precordial ST-segment elevation in structural heart disease: excitation failure by current-to-load mismatch. Heart Rhythm 7:: 238-248.
11. Bezzina CR, Rook MB, Groenewegen WA, Herfst LJ, van der Wal AC, et al. ((2003)) Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res 92:: 159-168.
12. Frustaci A, Priori SG, Pieroni M, Chimenti C, Napolitano C, et al. ((2005)) Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 112:: 3680-3687.
13. Zumhagen S, Spieker T, Rolinck J, Baba HA, Breithardt G, et al. ((2009)) Absence of pathognomonic or inflammatory patterns in cardiac biopsies from patients with Brugada syndrome. Circ Arrhythm Electrophysiol 2:: 16-23.
14. Papavassiliu T, Wolpert C, Fluchter S, Schimpf R, Neff W, et al. ((2004)) Magnetic resonance imaging findings in patients with Brugada syndrome. J Cardiovasc Electrophysiol 15:: 1133-1138.
15. Papavassiliu T, Veltmann C, Doesch C, Haghi D, Germans T, et al. ((2010)) Spontaneous type-1 ECG pattern is associated with cardiovascular magnetic resonance imaging changes in Brugada syndrome. Heart Rhythm 7:: 1790-1796.
16. Takagi M, Aihara N, Kuribayashi S, Taguchi A, Kurita T, et al. ((2003)) Abnormal response to sodium channel blockers in patients with Brugada syndrome: augmented localised wall motion abnormalities in the right ventricular outflow tract region detected by electron beam computed tomography. Heart 89:: 169-174.
17. Catalano O, Antonaci S, Moro G, Mussida M, Frascaroli M, et al. ((2009)) Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities. Eur Heart J 30:: 2241-2248.
18. Probst V, Wilde AAM, Barc J, Sacher F, Babuty D, et al. ((2009)) SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ Cardiovasc Genet 2:: 552-557.
19. Bezzina C, Veldkamp MW, van Den Berg MP, Postma AV, Rook MB, et al. ((1999)) A single Na+ channel mutation causing both Long-QT and Brugada syndromes. Circ Res 85:: 1206-1213.
20. Smits JPP, Koopmann TT, Wilders R, Veldkamp MW, Opthof T, et al. ((2005)) A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. J Mol Cell Cardiol 38:: 969-981.
21. Wilde AAM, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, et al. ((2002)) Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation 106:: 2514-2519.
22. Case MT, Sibinski LJ, Steffen GR, ((1984)) Chronic oral toxicity and oncogenicity studies of flecainide, an antiarrhythmic, in rats and mice. Toxicol Appl Pharmacol 73:: 232-242.
23. Royer A, van Veen TA, Le Bouter S, Marionneau C, Griol-Charhbili V, et al. ((2005)) Mouse model of SCN5A-linked hereditary Lenegre's disease: age-related conduction slowing and myocardial fibrosis. Circulation 111:: 1738-1746.
24. Remme CA, Verkerk AO, Nuyens D, van Ginneken ACG, van Brunschot S, et al. ((2006)) Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD. Circulation 114:: 2584-2594.
25. Casini S, Tan HL, Demirayak I, Remme CA, Amin AS, et al. ((2010)) Tubulin polymerization modifies cardiac sodium channel expression and gating. Cardiovasc Res 85:: 691-700.
26. Gavillet B, Rougier J, Domenighetti AA, Behar R, Boixel C, et al. ((2006)) Cardiac sodium channel Nav1.5 is regulated by a multiprotein complex composed of syntrophins and dystrophin. Circ Res 99:: 407-414.
27. Ueda K, Valdivia C, Medeiros-Domingo A, Tester DJ, Vatta M, et al. ((2008)) Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex. Proc Natl Acad Sci 105:: 9355-9360.
28. Moorman AF, Christoffels VM, ((2003)) Cardiac chamber formation: development, genes, and evolution. Physiol Rev 83:: 1223-1267.
29. Fahmi AI, Patel M, Stevens EB, Fowden AL, John JE, et al. ((2001)) The sodium channel β-subunit SCN3B modulates the kinetics of SCN5a and is expressed heterogeneously in sheep heart. J Physiol 537:: 693-700.
30. Watanabe H, Koopmann TT, Le Scouarnec S, Yang T, Ingram CR, et al. ((2008)) Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest 118:: 2260-2268.
31. London B, Michalec M, Mehdi H, Zhu X, Kerchner L, et al. ((2007)) Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation 116:: 2260-2268.
32. Alfakih K, Plein S, Bloomer T, Jones T, Ridgway J, et al. ((2003)) Comparison of right ventricular volume measurements between axial and short axis orientation using steady-state free precession magnetic resonance imaging. J Magn Reson Imaging 18:: 25-32.
33. Postema PG, van Dessel PFHM, de Bakker JMT, Dekker LRC, Linnenbank AC, et al. ((2008)) Slow and discontinuous conduction conspire in Brugada syndrome: a right ventricular mapping and stimulation study. Circ Arrhythm Electrophysiol 1:379-386.
34. Postema PG, van Dessel PFHM, Kors JA, Linnenbank AC, van Herpen G, et al. ((2010)) Local depolarization abnormalities are the dominant pathophysiologic mechanism for the type-1 ECG in Brugada syndrome: a study of electrocardiograms, body surface potential maps and vectorcardiograms during ajmaline provocation. J Am Coll Cardiol 55:789-797.
35. Tukkie R, Sogaard P, Vleugels J, de Groot IKLM, Wilde AAM, et al. ((2004)) Delay in right ventricular activation contributes to Brugada syndrome. Circulation 109:: 1272-1277.
36. Tang AS, Wells GA, Talajic M, Sheldon R, Connolly S, et al. ((2010)) Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 363:: 2385-2395.
37. Hardziyenka M, Surie S, de GrootJR, de Bruin-Bon HACMR, Knops RE, et al. ((2011)) Right ventricular pacing improves hemodynamics in right ventricular failure from pressure overload: an open observational proof-of-principle study in patients with chronic thromboembolic pulmonary hypertension. Europace 13:: 1753-1759.
38. Nademanee K, Veerakul G, Chandanamattha P, Chaothawee L, Ariyachaipanich A, et al. ((2011)) Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow trac epicardium. Circulation 123:: 1270-1279.
39. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, et al. ((2007)) Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115:: 442-449.